Go to main contents Go to main menus

Archives

contents area

detail content area

Review on global burden of tuberculosis, 2017
  • Date2019-02-21 19:13
  • Update2019-11-19 19:23
  • DivisionDivision of Strategic Planning for Emerging Infectious Diseases
  • Tel043-719-7271
Review on global burden of tuberculosis, 2017

Kim HeeAe, Shin JeeYeon, Kim HyeRim, Lee JaeEun, Kim JongHee, Kong Insik
Division of TB & HIV/AIDS Control, Center for Disease Prevention, KCDC

Tuberculosis (TB) is an infectious disease caused by the bacillus Mycobaterium tuberculosis. Internationally, it still remains one of the top 10 causes of death and leading causes from a single infectious agent. Ten millions of people continue to fall sick with TB each year. Based on “Global Tuberculosis Report 2018” published by World Health Organization (WHO), we reviewed and evaluated the situation of tuberculosis in Korea. Global tuberculosis incidence rate and mortality rate have been on the decrease of around 2% and 3% per year, respectively. The WHO’s End TB Strategy suggested targets with a 90% reduction in TB incidence and a 95% reduction in the absolute number of TB death by 2035, compared with the levels in 2015. The report showed that among 216 countries in 2017, the Republic of Korea was ranked 84th (70 per 100,000 population) in TB incidence and 99th (5.0 per 100,000 population) in TB mortality. Accelerating progress towards ending TB for 2030 requires much more commitments and actions at global, regional and national levels. The Korea Centers for Disease Control and Prevention has been intensifying national tuberculosis control program under the “the second National TB Control Plan” in accordance with the End TB strategy of WHO and the resolution of the United Nations (UN)’s first high-level meeting on TB.

Keywords: Tuberculosis, World Health Organization, Causes of death, Incidence, Mortality
This public work may be used under the terms of the public interest source + commercial use prohibition + nonrepudiation conditions This public work may be used under the terms of the public interest source + commercial use prohibition + nonrepudiation conditions
TOP